Mednet Logo
HomePediatric Hematology/Oncology
Pediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

What are best practices for oncologists during the national platinum shortage?

11
13 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center

In breast cancer, we are prioritizing patients with curable disease in which platinum agents are a critical part of the regimen or have actually shown a clear advantage (the only example of this is shown below in bold).Use an alternative to a carboplatin-based regimen whenever possible. If no altern...

Do you screen adults in your practice with sickle cell disease for silent cerebral infarcts?

5
1 Answers

Mednet Member
Mednet Member
Hematology · Boston University School of Medicine

The details of the ASH guidelines regarding adults are complex. It was not my practice to screen all patients. More than 50% of adults have silent infarction. Screening requires MRI and this, according to the guidelines, needs careful attention to many details before it is reliable. There are no pro...

Do you give post-operative radiation to Ewing sarcoma if there is poor histologic response to neoadjuvant therapy in a completely resected tumor?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · St Jude Children's Research Hospital

US Ewing studies conducted through COG have used histologic response in more recent protocols to play a key role in how margins are assessed, such that patients with >90% necrosis and inflammatory or coagulative necrosis at the margin require RT, while those with bland scar or fibrous tissue do not....

What is your follow up schedule after completion of RT for pediatric rhabdomyosarcoma?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Stanford University School of Medicine

Imaging surveillance is an interesting and yet complicated issue. If a child is enrolled upon a prospective randomized trial for which informed consent has been given, then every effort should be made to follow the protocol guidelines, which are designed to answer a protocol question. However, patie...

Would you recommend prophylactic retro-peritoneal RT in an adolescent with paratesticular rhabdomyosarcoma, s/p radical inguinal orchiectomy without a lymph node dissection?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · St Jude Children's Research Hospital

Ideally, in children over 10 years of age with a diagnosis of paratesticular RMS, a retroperitoneal LN sampling (taking 7-12 LNs) at diagnosis should be performed unless obvious gross disease in the nodal region is present. The risk of occult LN involvement is higher in those children 10 years or ol...

For patients on immune checkpoint inhibitors presenting with chest pain, dyspnea, fatigue, and troponin elevation, would you recommend early initiation of high dose steroids for empiric treatment of ICI myocarditis while pursuing workup with coronary angiogram, echocardiogram, and/or cardiac MRI, or wait until alternative etiologies have been ruled out?

2
2 Answers

Mednet Member
Mednet Member
Cardiology · UConn Health

This question raises an important point that the clinical presentation of ICI-associated myocarditis often overlaps with other cardiovascular disorders, including acute coronary syndrome, chronic CAD, congestive heart failure, and other nonischemic cardiomyopathies. Therefore, prompt initiation of w...

How do you manage patients blood pressures while on anti-angiogenic TKIs?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Myo Thant, MD

Advise patients to take BP daily, and inform us if the BP is high.

Should all patients with a remote history of immunotherapy, chemotherapy and/or radiation therapy have a baseline TTE regardless of ASCVD risk?

2 Answers

Mednet Member
Mednet Member
Cardiology · UConn Health

The current ASCVD risk assessment calculators we have available do not contain cancer-specific parameters and thus are inadequate for accurate assessment of a cancer survivor's risk of developing CHF and ischemic heart disease. If patients have received mediastinal radiation therapy or high-dose ant...

For a recurrent medulloblastoma in the posterior fossa several years after initial standard risk therapy (23.4 Gy CSI), and in which the patient is still less than 18, how would you approach re-irradiation?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Washington Medical Center

If the recurrences are localized to the resection bed, I would re-irradiate only the recurrences (and possibly the entire resection bed depending on number of recurrences). If there is evidence of CSF dissemination (recurrences not associated with primary--whether in posterior fossa or not) then CSI...

During induction therapy for acute leukemia, when do you decide to discontinue the antimicrobial prophylaxis?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Washington

Antimicrobial prophylaxis (PPX) during treatment of acute leukemia can take several forms, and it is not always directly associated with blood counts.Fungal PPXDuring induction for AML, there are randomized data supporting posaconazole over fluconazole or itraconazole (Cornely, et al. New Engl J Med...